Trial Profile
A Retrospective Survey to Evaluate the Impact of Hyzaar on Uric Acid in the Management of Hypertensive Patients in Normal Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme; Organon
- 09 Jun 2011 New trial record